A number of recommended options exist for screening those 30 to 65. This includes cervical cytology every 3 years, HPV testing every 5 years, or HPV testing together with cytology every 5 years. Screening is not beneficial before age 25, as the rate of disease is low. Screening is not beneficial in women older than 60 years if they have a history of negative results. The American Society of Clinical Oncology guideline has recommend for different levels of resource availability.
A number of recommended o.ptions exist for screening those 30 to 65 This includes cervical cytology every 3 years, HPV testing every 5 years, or HPV testing together with cytology every 5 years Screening is not beneficial before age 25, as the rate of disease is low. Screening is not beneficial in women older than 60 years. if they have a history of negative results. The American Society of Clinical Oncology guideline has recommend for different levels of resource availability.